How CPAP mask designs affect rebreathing of exhaled air in obstructive sleep apnea
Studies how CPAP mask designs affect rebreathed carbon dioxide in people with obstructive sleep apnea.
Key facts
- Who runs it
- Brigham and Women's Hospital
- Where
- Boston, United StatesSee the site
- Trial code
- Registry title
- Assessment of Circuit Rebreathing During CPAP Therapy
- Status
- Recruiting
- People taking part
- 13 people, planned
- Started
- 27 May 2025
- Planned end
- 1 Dec 2025
- Type of study
- Interventional, 11 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Continuous positive airway pressure (CPAP)
- Mask exhaust port flow
- Record updated
- 14 July 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with moderate to severe obstructive sleep apnea who use or have used CPAP. It studies how mask designs affect breathing back exhaled CO₂ during sleep.
- Age
- 21 to 70 years
- Sex
- All sexes can join.
- Disease stage
- Moderate to severe obstructive sleep apnea (AHI>20, meaning more than 20 breathing pauses or drops per hour of sleep). BMI 18-40 kg/m2.
- Earlier treatment
- People must say they use CPAP now or have used it before. Their CPAP pressure must be at most 13 cmH2O, if known.
Main reasons for not taking part
- Severe mouth-breathing, as reported by the person
- Needing oxygen at night or other breathing support
- Severe heart, blood vessel or lung disease
- Any unstable or sudden medical condition
- Any other sleep disorder besides OSA, including insomnia
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Moderate to severe OSA (AHI>20)
- Self-reported CPAP users or have previously used CPAP
- Self-reported holding pressure of maximum 13 cmH2O (if known)
- Age: 21-70
- BMI: 18-40 kg/m2
Who cannot take part
- Severe cardiovascular or pulmonary disease
- Any unstable or acute medical condition
- Any additional sleep disorder, including insomnia, except for OSA
- Self-reported severe mouth-breathing
- Requirement for nocturnal supplemental oxygen or other ventilatory support
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 21 and 70 years old?
Where in United States
- Brigham and Women's HospitalBoston, United StatesContact: Atqiya Aishah, PhDTaking people
About the trial
What the trial wants to find out
The goal of this research is to better understand how different CPAP mask designs affect airflow and rebreathing of exhaled carbon dioxide (CO₂) during sleep in individuals with obstructive sleep apnea (OSA).
The 11 groups in the trial
- 5 cmH2O with 35L/sTreatment being tested
35 L/s exhaust flow with 5 cmH₂O PAP
Treatment: Continuous positive airway pressure (CPAP) and Mask exhaust port flow
- 5 cmH2O with 23L/sTreatment being tested
23 L/s exhaust flow with 5 cmH₂O PAP
Treatment: Continuous positive airway pressure (CPAP) and Mask exhaust port flow
- 5 cmH2O with 18L/sTreatment being tested
18 L/s exhaust flow with 5 cmH₂O PAP
Treatment: Continuous positive airway pressure (CPAP) and Mask exhaust port flow
- 5 cmH2O with 13L/sTreatment being tested
13 L/s exhaust flow with 5 cmH₂O PAP
Treatment: Continuous positive airway pressure (CPAP) and Mask exhaust port flow
- 5 cmH2O with 8L/sTreatment being tested
8 L/s exhaust flow with 5 cmH₂O PAP
Treatment: Continuous positive airway pressure (CPAP) and Mask exhaust port flow
- 0 cmH2O with 35L/sPlacebo, for comparison
35 L/s exhaust flow with 0 cmH₂O PAP
Treatment: Mask exhaust port flow
- 10 cmH2O with 35L/sTreatment being tested
35 L/s exhaust flow with 10 cmH₂O PAP
Treatment: Continuous positive airway pressure (CPAP) and Mask exhaust port flow
- 10 cmH2O with 23L/sTreatment being tested
23 L/s exhaust flow with 10 cmH₂O PAP
Treatment: Continuous positive airway pressure (CPAP) and Mask exhaust port flow
- 10 cmH2O with 18L/sTreatment being tested
18 L/s exhaust flow with 10 cmH₂O PAP
Treatment: Continuous positive airway pressure (CPAP) and Mask exhaust port flow
- 10 cmH2O with 13L/sTreatment being tested
13 L/s exhaust flow with 10 cmH₂O PAP
Treatment: Continuous positive airway pressure (CPAP) and Mask exhaust port flow
- 10 cmH2O with 8L/sTreatment being tested
8 L/s exhaust flow with 10 cmH₂O PAP
Treatment: Continuous positive airway pressure (CPAP) and Mask exhaust port flow
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Assessment of Circuit Rebreathing During Continuous Positive Airway Pressure (CPAP) Therapy
- Plain-language title
- How CPAP mask designs affect rebreathing of exhaled air in obstructive sleep apneaGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT07062770, who can take part
- Record updated
- 14 July 2025